Cite
Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the 'real world': the Rapamycin-Eluting stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry.
MLA
Lemos PA, et al. “Unrestricted Utilization of Sirolimus-Eluting Stents Compared with Conventional Bare Stent Implantation in the ‘Real World’: The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry.” Circulation, vol. 109, no. 2, Jan. 2004, pp. 190–95. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=106673221&authtype=sso&custid=ns315887.
APA
Lemos PA, Serruys PW, van Domburg RT, Saia F, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Daemen J, Liu TKK, McFadden E, Sianos G, Hofma SH, Smits PC, van der Giessen WJ, & de Feyter PJ. (2004). Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the “real world”: the Rapamycin-Eluting stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry. Circulation, 109(2), 190–195.
Chicago
Lemos PA, Serruys PW, van Domburg RT, Saia F, Arampatzis CA, Hoye A, Degertekin M, et al. 2004. “Unrestricted Utilization of Sirolimus-Eluting Stents Compared with Conventional Bare Stent Implantation in the ‘Real World’: The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry.” Circulation 109 (2): 190–95. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=106673221&authtype=sso&custid=ns315887.